This falling ticker seems ripe for a bullish reversal, but things are still complicated for this recently IPO'd company's shares.
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
AstraZeneca tops Q2 earnings and revenue estimates as strong demand for oncology and rare disease drugs helps offset growing generic competition across key products.
Despite the lower-than-expected sales outlook, STM can be looked upon as an attractive investment option now.
Big Three automaker Ford reported its Q2 results after the close.
Big Three automaker Ford reported its Q2 results after the close.
Big Three automaker Ford is on deck to report second quarter results, with investors focused on whether management follows rival General Motors in lifting its full-year outlook, and on how deep the softness in electric-vehicle demand runs across the lineup.
PBI gears up to report Q2 2026 earnings on July 29, with SendTech momentum, Presort strength and cost discipline in focus.
The electric vehicle stock is now down nearly 40% from its high.
Monolithic Power is riding AI-driven demand and expanding manufacturing capacity, but can those strengths power another earnings beat this quarter?
ASRV returns to earnings per share in Q2 2026 as higher net interest income, stronger fee revenues and improved credit quality offset rising expenses.
Procter & Gamble usually isn't an exciting stock -- and that may be the reason to consider it, heading into earnings.
Southern Copper beats EPS estimates as record revenues, profit and cash flow were fueled by higher metal prices, even as copper production and sales volumes declined.
Arm stock has shed nearly a third of its value in just one month, yet the company's AI data center pipeline tells a very different story heading into Wednesday's earnings report.
CTSH's Q2 results are likely to benefit from strong bookings, AI momentum and acquisition support, but macro uncertainty and weak discretionary demand remain key risks.
Earlier this month, reports indicated that Mastercard was exploring a majority stake sale of its UK payments subsidiary Vocalink to British banks, amid concerns about foreign ownership of critical UK retail payment infrastructure. At the same time, analyst forecasts pointing to higher quarterly earnings per share and revenue have highlighted how Mastercard’s core payments engine remains central to the investment story. Against this backdrop of potential Vocalink divestment and upbeat...
KKR's Q2 results, set to be reported on July 30, are likely to benefit from higher AUM, management fees and revenues, while elevated expenses remain a concern.
Semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) will be announcing earnings results this Monday after market hours. Here’s what investors should know.
CNI beats Q2 estimates as grain and energy volumes lift revenues, while higher fuel costs pressure efficiency and the railroad raises its 2026 outlook.
The social media company may also become a cloud computing provider.
Apple stock is nearing fresh records ahead of its earnings release. The company is set to report earnings after the bell on Thursday in what will be Tim Cook's last earnings call as CEO. It will also be the first quarterly release since the company raised prices to offset higher memory costs.
AMD Gets Massive Wall Street Upgrade as AI Revenue Outlook Soars
Liberty Energy beats Q2 estimates and trades below its subindustry on forward sales, but margin pressure and heavy growth spending keep the outlook mixed.
Grab heads into Q2 2026 earnings with revenues expected to rise 22.3%, supported by deliveries, Mobility and Financial Services despite major headwinds.
Seagate is slated to report earnings after the closing bell Tuesday, and traders are anticipating a big move from the hard drive maker’s stock following the results.
Harmony Biosciences, Acadia, Biogen, Insmed and Agios show positive Earnings ESPs ahead of Q2 results, setting up closely watched earnings reports.
CI's Q2 earnings are likely to face pressure from fewer insured medical customers and a higher MCR despite expected revenue growth.
FORM heads into Q2 earnings with AI, HBM and advanced packaging momentum, but valuation and trade risks temper the upside.
The volume of stock sales from early stakeholders could dwarf the IPO after SpaceX's first earnings report.